Cecilia Maria Katarina Magnusson

Cecilia Maria Katarina Magnusson

Professor/Överläkare
Besöksadress: Solnavägen 1 E, 11365 Stockholm
Postadress: K9 Global folkhälsa, K9 GPH Magnusson, 171 77 Stockholm
Del av:

Om mig

  • Jag tog läkarexamen vid Uppsala universitet 1995 och disputerade vid Karolinska Institutet 1998 med fokus på hormonrelaterade faktorer och bröstcancer. Efter en postdoktoral forskartjänst inom cancerepidemiologi vid University of Oxford gjorde jag forskar-AT vid Karolinska Universitetssjukhuset. Jag blev docent 2007 och utsågs 2012 till verksamhetschef för Region Stockholms Centrum för epidemiologi och samhällsmedicin.

    I dag leder jag en forskargrupp med fokus på prevention, intervention och mekanismer inom folkhälsa. Jag är specialist i socialmedicin och utnämndes till professor vid Karolinska Institutet 2025.

Forskningsbeskrivning

  • Mitt ämne, socialmedicin, handlar om att förstå hur hälsa fördelas i befolkningen och vilka faktorer som påverkar den. I min forskargrupp fokuserar vi särskilt på tydliga förändringar i förekomsten av sjukdomar och riskfaktorer, samt på växande skillnader i hälsa mellan olika sociodemografiska grupper. Detta är viktigt för att tidigt kunna uppmärksamma politiker, myndigheter och andra aktörer inom välfärden på potentiella hot mot folkhälsan.

    För närvarande leder jag två större forskningsprojekt. I det ena undersöker vi hur jämlik användningen av hormonbehandling i klimakteriet är, samt vilka risker och fördelar behandlingen medför. Det andra fokuserar på den nya “nikotinepidemin”, som framför allt drabbar unga kvinnor, och innebär att vi studerar hur rökfritt nikotin påverkar hälsan hos gravida och nyfödda.

    Min forskargrupp omfattar även tre ytterligare team som fokuserar på forskning om fysisk aktivitet, kardiometabol hälsa respektive klimatrelaterade hälsoeffekter.

Utvalda publikationer

  • Article: LANCET ONCOLOGY. 2024;25(11):1413-1423
    Rumgay H; Nethan S; Shah R; Vignat J; Ayo-Yusuf O; Chaturvedi P; Guerra ENS; Gupta PC; Gupta R; Liu S; Magnusson C; Parascandola M; Paulino YC; Rezaei N; Siddiqi K; Warnakulasuriya S; Lauby-Secretan B; Soerjomataram I
  • Article: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2024;331(14):1205-1214
    Ahlqvist VH; Sjoeqvist H; Dalman C; Karlsson H; Stephansson O; Johansson S; Magnusson C; Gardner RM; Lee BK
  • Article: JOURNAL OF INTERNAL MEDICINE. 2017;281(4):398-406
    Carlsson S; Andersson T; Araghi M; Galanti R; Lager A; Lundberg M; Nilsson P; Norberg M; Pedersen NL; Trolle-Lagerros Y; Magnusson C
  • Article: JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS. 2015;45(6):1766-1773
    Idring S; Lundberg M; Sturm H; Dalman C; Gumpert C; Rai D; Lee BK; Magnusson C
  • Article: LANCET ONCOLOGY. 2012;13(11):1141-1151
    Beral V; Bull D; Pirie K; Reeves G; Peto R; Skegg D; LaVecchia C; Magnusson C; Pike MC; Thomas D; Hamajima N; Hirose K; Tajima K; Rohan T; Friedenreich CM; Calle EE; Gapstur SM; Patel AV; Coates RJ; Liff JM; Talamini R; Chantarakul N; Koetsawang S; Rachawat D; Marcou Y; Kakouri E; Duffy SW; Morabia A; Schuman L; Stewart W; Szklo M; Coogan PF; Palmer JR; Rosenberg L; Band P; Coldman AJ; Gallagher RP; Hislop TG; Yang P; Cummings SR; Canfell K; Sitas F; Chao P; Lissowska J; Horn-Ross PL; John EM; Kolonel LM; Nomura AMY; Ghiasvand R; Hu J; Johnson KC; Mao Y; Callaghan K; Crossley B; Goodill A; Green J; Hermon C; Key T; Lindgard I; Liu B; Collins R; Doll R; Bishop T; Fentiman IS; De Sanjose S; Gonzaler CA; Lee N; Marchbanks P; Ory HW; Peterson HB; Wingo P; Ebeling K; Kunde D; Nishan P; Hopper JL; Eliassen H; Gajalakshmi V; Martin N; Pardthaisong T; Silpisornkosol S; Theetranont C; Boosiri B; Chutivongse S; Jimakorn P; Virutamasen P; Wongsrichanalai C; Neugut A; Santella R; Baines CJ; Kreiger N; Miller AB; Wall C; Tjonneland A; Jorgensen T; Stahlberg C; Pedersen AT; Flesch-Janys D; Hakansson N; Cauley J; Heuch I; Adami HO; Persson I; Weiderpass E; Chang-Claude J; Kaaks R; McCredie M; Paul C; Spears GFS; Iwasaki M; Tsugane S; Anderson G; Daling JR; Hampton J; Hutchinson WB; Li CI; Malone K; Mandelson M; Newcomb P; Noonan EA; Ray RM; Stanford JL; Tang MTC; Weiss NS; White E; Izquierdo A; Viladiu P; Fourkala EO; Jacobs I; Menon U; Ryan A; Cuevas HR; Ontiveros P; Palet A; Salazar SB; Aristizabal N; Cuadros A; Tryggvadottir L; Tulinius H; Riboli E; Andrieu N; Bachelot A; Le MG; Bremond A; Gairard B; Lansac J; Piana L; Renaud R; Clavel-Chapelon F; Fournier A; Touillaud M; Mesrine S; Chabbert-Buffet N; Boutron-Ruault MC; Wolk A; Torres-Mejia G; Franceschi S; Romieu I; Boyle P; Lubin F; Modan B; Ron E; Wax Y; Friedman GD; Hiatt RA; Levi F; Kosmelj K; Primic-Zakelj M; Ravnihar B; Stare J; Ekbom A; Erlandsson G; Beeson WL; Fraser G; Peto J; Hanson RL; Leske MC; Mahoney MC; Nasca PC; Varma AO; Weinstein AL; Hartman ML; Olsson H; Goldbohm RA; van den Brandt PA; Palli D; Teitelbaum S; Apelo RA; Baens J; de la Cruz JR; Javier B; Lacaya LB; Ngelangel CA; La Vecchia C; Negri E; Marubini E; Ferraroni M; Gerber M; Richardson S; Segala C; Gatei D; Kenya P; Kungu A; Mati JG; Brinton LA; Freedman M; Hoover R; Schairer C; Ziegler R; Banks E; Spirtas R; Lee HP; Rookus MA; van Leeuwen FE; Schoenberg JA; Graff-Iversen S; Selmer R; Jones L; McPherson K; Neil A; Vessey M; Yeates D; Mabuchi K; Preston D; Hannaford P; Kay C; McCann SE; Rosero-Bixby L; Gao YT; Jin F; Yuan J-M; Wei HY; Yun T; Zhiheng C; Berry G; Booth JC; Jelihovsky T; MacLennan R; Shearman R; Hadjisavvas A; Kyriacou K; Loisidou M; Zhou X; Wang Q-S; Kawai M; Minami Y; Tsuji I; Lund E; Kumle M; Stalsberg H; Shu XO; Zheng W; Monninkhof EM; Onland-Moret NC; Peeters PHM; Katsouyanni K; Trichopoulou A; Trichopoulos D; Tzonou A; Baltzell KA; Dabancens A; Martinez L; Molina R; Salas O; Alexander FE; Anderson K; Folsom AR; Gammon MD; Hulka BS; Millikan R; Chilvers CED; Lumachi F; Bain C; Schofield F; Siskind V; Rebbeck TR; Bernstein LR; Enger S; Haile RW; Paganini-Hill A; Ross RK; Ursin G; Wu AH; Yu MC; Ewertz DM; Clarke EA; Bergkvist L; Gass M; O'Sullivan MJ; Kalache A; Farley TMM; Holck S; Meirik O; Fukao A
  • Article: INTERNATIONAL JOURNAL OF CANCER. 1999;81(3):339-344
    Magnusson C; Baron JA; Correia N; Bergström R; Adami HO; Persson I

Artiklar

Alla övriga publikationer

Forskningsbidrag

  • Swedish Research Council
    1 January 2026 - 31 December 2029
    Migrant health, particularly reproductive health, is a growing public health priority. Pregnancy weight gain guidelines and neonatal growth references are widely used in clinical care to guide maternal and neonatal assessments. However, these guidelines and references are primarily based on data from non-migrant populations in high-income countries, and their relevance for migrant women and their children remains uncertain.This project will therefore examine the validity, clinical application, and patient perspectives of these guidelines and references in the context of migrant health. It comprises three work packages: 1) registry-based studies of over one million pregnancies to assess whether the predictive capacity of current guidelines and references for a wide range of adverse pregnancy and childhood outcomes varies across maternal birth regions
    2) mixed-methods studies to explore how healthcare professionals apply them in clinical practice
    and 3) qualitative studies to understand how pregnant women perceive them.The project builds on ongoing research and unique national registry data, and is led by a multidisciplinary team with strong expertise in migrant and reproductive health, including the main applicant, who has over 15 years of experience in maternal and infant health. The findings are expected to inform clinical guidelines and health policies, reduce reproductive health inequalities, and promote more equitable and individually adapted care.
  • Forte
    1 January 2026 - 31 March 2028
  • White or black: Perinatal risks related to snuff use in pregnancy
    Karolinska Institutet
    1 January 2025 - 31 December 2025
  • Anpassning till extrema temperaturer under graviditet: historiska trender och framtidsscenarier
    Swedish Council for Working Life and Social Research
    1 January 2025 - 31 December 2027
  • FORTE
    1 January 2025 - 31 December 2025
  • Swedish Research Council for Health Working Life and Welfare
    1 January 2025 - 31 December 2027
    Research problem and specific questionsNon-optimal or extreme temperatures negatively affect public health and well-being. Their detrimental impacts are unevenly distributed, with pregnant women and infants bearing a disproportionate burden. Moreover, both the occurrence of temperature extremes, notably heatwaves, and their impacts are projected to increase under future climate change.Taking Sweden as a case-in-point, this project aims:to study the vulnerability to non-optimal and extreme temperatures in pregnant women and infants in Sweden
    to study the role of adaptation to non-optimal and extreme temperatures on maternal and infant health
    to develop scenarios of maternal and infant related health outcomes from plausible future extreme temperatures in Sweden accounting for socio-political dimensions of adaptation processes.Data and methodAccessing novel data resources from Sweden (DOHaD), we will quantify the excess risk of maternal and infant related health outcomes attributed to non-optimal and extreme temperatures. We will include an analysis of historical trends and drivers of the adaptation comparing Sweden with England and Italy-Lombardy Region, a temperate oceanic and a Mediterranean climate country. Leveraging available climate projections, we will also develop scenarios of maternal and infant related health outcomes of plausible future temperature extremes using storylines.Societal relevance and utilisationThis effort is timely: anthropogenically-driven global warming has led to an increased frequency, duration and intensity of heatwaves, a trend that is foreseen to continue in the coming decades. Concurrently, cold spells in several mid-latitude regions continue to be the norm, in part due to enhanced temperature variability. This points to the urgency of reducing the impacts on the most vulnerable, such as pregnant women and infants, by leveraging early-warning systems, and developing new recommendations and long-term adaptation strategies.Plan for project realisationThe project will last 3 years (overall cost 4 999 613 SEK) and consists of 3 WPs. Costs cover salaries (3 675 334 SEK), and communication, travel and overhead (1 324 279 SEK). Raffetti with expertise in public health and epidemiology will lead the project in collaboration with experts in medical, physical and critical social sciences.The project will be part of the Swedish Center for Impacts of Climate Extremes.
  • Swedish Research Council
    1 January 2024 - 31 December 2027
    The use of smokeless nicotine products (SNP) is increasing fast among young people in high-income countries, especially among women. While the adverse perinatal effects of smoking in pregnancy are well established, and the marketing and sales of smoked tobacco products thus strictly regulated, less is known about such effects of SNP. Young women’s attitudes towards, and risk perception of, SNP use in pregnancy have never been surveyed in Sweden. We therefore propose a project to fill these knowledge gaps, taking a multidisciplinary approach. The work will rest on a recent register-based cohort study, involving all pregnancies in Sweden since 1999 (N=2.4 million) with data from health data registers. We will use “snus use”, as recorded at various points of gestation in the Medical Birth Register (MBR), as our main exposure and proxy for SNP use. In addition to perinatal outcomes (e.g., gestational diabetes and preterm birth) assessed from health registers, we will explore associations between snus use and foetal growth and growth velocity identified from ultrasounds measures. We will also validate the MBR data on snus using biomarkers analysed from maternal sera. Lastly, we will conduct semi-structured interviews with young women to improve the understanding of risk perceptions. We believe that the expected research findings are important to guide the development of interventions that can mitigate any negative public health consequences of the current surge in SNP use.
  • Swedish Research Council
    1 December 2023 - 30 November 2026
    The COVID-19 pandemic has raised significant concerns about the potential long-term effects on women and infants exposed to SARS-CoV-2 infection during pregnancy. This points to the urgency of developing balanced policy responses during COVID-19 epidemic phases and future pandemics.Taking Sweden and England as a case-in-point, this project aims to address the following questions: 1) What are the adverse health outcomes after the delivery associated with SARS-CoV-2 infection during pregnancy? 2) What are the adverse health outcomes associated with intrauterine exposure to SARS-CoV-2 infection in infants? 3) How can preventive strategies mitigate the impacts on women and infant health of a potential future respiratory virus-related pandemic?Accessing novel data resources from Sweden and England, we will quantify the excess risk of 2-year post-delivery adverse health outcomes in women and offspring exposed to SARS-CoV-2 infection during pregnancy and compare with influenza (as a positive control). We will then develop future pandemic scenarios using ‘storylines’.This effort is timely: 1) to reduce the impact of SARS-CoV-2 infection during pregnancy on women and infant health
    2) to support better-informed prevention strategies (e.g. targeted vaccination campaigns, early monitoring) for high-risk individuals
    3) to reduce the impacts of future pandemics on the most vulnerable, such as pregnant women and offspring (e.g. new recommendations and long-term contingency plans).
  • Swedish Research Council for Environment Agricultural Sciences and Spatial Planning
    1 December 2023 - 30 November 2027
    Temporally compound hydroclimate extremes, such as drought-to-flood and heatwave-drought transitions, are consecutive and/or partially overlapping events. Anthropogenic climate change exacerbates their frequency and intensity, making them the norm in many regions. Lack of impact databases and the complex socio-physical feedbacks underlying the genesis of such extremes pose a formidable challenge to sustainable transformation.This project aims to enhance understanding of temporally compound hydroclimate extremes and identify adaptation actions that promote sustainable transformation. Specific aims include: 1) developing a multi-sectoral impact database of such extremes in Europe since 1940
    2) analyzing (un)sustainable transformation following extreme events through two case studies
    3) proposing a novel system dynamics modelling framework for a system view, and 4) developing scenarios to evaluate public health and societal impacts of future extremes under different development pathways.A thorough understanding of such extremes is crucial for developing a sustainable society, as their impact is likely to disproportionately affect vulnerable groups. In addition, societal responses after an extreme may exacerbate inequalities and contribute to the genesis of successive extremes. This makes the planned research highly timely.The project will engage with stakeholders and end-users to ensure their needs are met in achieving a fair and effective response to climate change.
  • Swedish Research Council for Health Working Life and Welfare
    1 January 2023 - 31 December 2027
    Research problem and specific questionsYoung LGBTQ+ people i.e. Lesbians, Gays, Bisexuals, Transgender and Queer or Questioning persons have high risks for mental health problems but the reasons are unclear. This project will, therefore, focus on mental health of young LGBTQ+ people aged 16-29 years and vulnerable subgroups. Our research questions are:  Have the mental health outcomes of young LGBTQ+ people changed over time (2006-2021)? How has the COVID-19 pandemic impacted on the mental health of young LGBTQ people?How does the mental health of young LGBTQ+ people evolve as they transition into adulthood and what are the risk and protective factors?Why do bisexuals, transgender persons and persons with gender dysphoria have worse mental health than other LGBTQ+ subgroups i.e. gays and lesbians?What do young LGBTQ+ people think are the causes of mental ill-health among their peers and what support do they need? What works and is lacking in existing support to young LGBTQ+ people within first line health services and in society?Data and methodThe project has two parts. Part 1 is quantitative and based on the Stockholm Public Health Cohort (SPHC), a longitudinal (2002-2021) and population-based cohort (N≈140,000) with linked self-reported and registry data. The SPHC includes information on LGBTQ+ status and health, lifestyle and social factors, making it a world-unique dataset to study mental health of young LGBTQ+ people. Part 2 is qualitative and based on focus group discussions and in-depth interviews with young LGBTQ+ people.Plan for project realisationRegion Stockholm´s Centre for epidemiology and community medicine will host the project and has funded the SPHC. We ask for funds to cover costs for salaries for the project staff, data management and research- and conference travel.RelevanceAbout 15% of young people 16-29 years in Sweden (N=211,000) are LGBTQ+ persons, and young LGBTQ+ people have poorer mental health than their non-LGBTQ+ peers. It is, therefore, of great societal interest to address mental health inequities in this population. Our studies will span a very broad spectrum of young LGBTQ+ people, including gays, lesbians, bisexuals, transgender and queer persons and persons with gender dysphoria, making up a substantial share of young people in Sweden. The project will add new knowledge on the mental health of young LGBTQ+ people and help optimize the societal support and reduce inequality.
  • Sexual and reproductive health and rights for young people: how is the availability, content and quality of care affected by the digitization of healthcare during the covid-19 pandemic?
    Swedish Research Council
    1 December 2021 - 30 November 2024
  • National Institute of Neurological Disorders and Stroke
    1 June 2019 - 30 April 2024
  • Swedish Research Council
    1 January 2019 - 31 December 2021
  • Swedish Research Council for Health Working Life and Welfare
    1 January 2019 - 31 December 2022
  • Swedish Research Council for Health Working Life and Welfare
    1 January 2018 - 31 December 2022
  • Swedish Research Council for Health Working Life and Welfare
    1 January 2018 - 31 December 2022
  • Swedish Research Council for Health Working Life and Welfare
    1 October 2017 - 30 September 2021
  • Swedish Research Council
    1 January 2017 - 31 December 2020
  • Swedish Research Council for Health Working Life and Welfare
    1 January 2016 - 31 December 2018
  • Swedish Research Council
    1 January 2016 - 31 December 2018
  • Visa fler

Anställningar

  • Professor/Överläkare, Socialmedicin, Global folkhälsa, Karolinska Institutet, 2025-
  • Adjungerad Professor, Global folkhälsa, Karolinska Institutet, 2021-2025
  • Adjungerad Professor, Global folkhälsa, Karolinska Institutet, 2013-2020

Examina och utbildning

  • Docent, Epidemiologi, Karolinska Institutet, 2007

Nyheter från KI

Kalenderhändelser från KI